about
Perioperative chemotherapy in gastroesophageal cancer. A retrospective monocenter evaluation of 42 cases.Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.Retrospective Analysis of the Blood Component Utilization in a University Hospital of Maximum Medical CareThoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision.NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR.Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor.Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients.Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.Tissue-factor fusion proteins induce occlusion of tumor vessels.DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases.Mixed response in interim positron emission tomography/computed tomography leads to detection of a gastrointestinal stromal tumor in a patient with mediastinal diffuse large B-cell lymphoma.Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases.Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculatureTargeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell TransplantationNon-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsisInfarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experienceOverexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemiaClinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcomaAntiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in miceCirculating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemiaAmsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysisCombined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancerInduction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patientsEfficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphomaNivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantationRemissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's diseaseCore Data Elements in Acute Myeloid Leukemia: A Unified Medical Language System-Based Semantic Analysis and Experts' ReviewFulminant invasive pulmonary mucormycosis with Rhizopus oryzae in a patient with severe aplastic anaemia and common variable immunodeficiencyFirst-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
P50
Q35346910-3444D6D5-61D6-49A8-8D3A-307476A47851Q35409847-80EB2FEF-D211-42E8-9F5C-1FE6E4AF25BBQ35998244-5031B27B-45A5-427A-8EC0-F531F132FD0BQ36895846-F85BEEF8-E8EC-4546-8229-004F37EF77C4Q36916334-A93E5981-403C-47D3-B391-C7197022DA36Q37696156-741A49D8-C603-4FDE-B252-E86C6C35DFC0Q38840536-51B27DC4-8FB7-4761-92C0-6B4C69F9175BQ39180742-8CC5D74C-C4A5-4BA4-8130-A58B2414AC80Q39363153-43AC9AB8-C05E-4F06-9111-39A237972525Q40050475-36575177-F716-4F4F-9D65-2C822F75E9C9Q41564670-B90D785D-5E74-4B9F-8418-72C93AC89D8DQ43077949-A6FB621F-692B-4619-950D-FC226C959E8DQ44610536-F86250A1-A7A8-4235-B3BC-2AF7BF4C7E4CQ45991699-7FA25675-BDE7-4537-9AB1-05A14D32BDFBQ46689453-A13F01EC-56EE-48F5-B757-AB6DB372D040Q53135679-4426EE7D-9A3C-482C-82AC-BC895DF5279BQ53306754-61448FB8-D5DC-4211-913E-BA2EE9E45A04Q55216228-2EF68857-B254-44EB-AD4A-2B486E577B22Q57911931-FFA8EB47-3D65-40D6-8375-DED7D0A8094BQ57911935-7C5C6085-F151-454F-A7A0-84398F03CB71Q59260950-7973B5B5-8C92-4D7E-9C81-44CD955CE169Q60651985-84BD3385-1D99-498F-B28F-BCF7886A6309Q60652026-EDD0E429-7A77-4431-A9DA-EC86E7AC57B9Q79849522-55CA3A28-6E47-456E-911E-ADDA0FD1B964Q80465220-1CD36D0B-78F4-46BA-B1D4-E5D561634BF2Q80540771-A061FBB6-8FF2-431B-8AC1-D351CFEEA1FDQ80735369-3A8458BA-F214-49A1-AA97-4FE871D5E756Q83126810-9A9BE591-626F-4C75-878F-2F21C3D0A014Q84654758-FDEFC6EA-B960-4132-BB9A-E91185BCFB17Q84904962-0D5E2733-9CAD-4719-BBE7-7531B7F6B4CCQ86654387-A07C2ABD-4C49-4884-B0DF-818219CCC596Q86960788-81C3E8A0-4ACE-4FFF-9341-87077236DAFDQ92587525-6F0C92A9-206A-4872-A4C3-70C8DE13DF28Q95385909-9551874A-988F-4157-BAFE-800C308BE41DQ96226710-5EC8851E-D145-45E7-8D32-300C6398538A
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Torsten Kessler
@ast
Torsten Kessler
@en
Torsten Kessler
@es
Torsten Kessler
@nl
Torsten Kessler
@sl
type
label
Torsten Kessler
@ast
Torsten Kessler
@en
Torsten Kessler
@es
Torsten Kessler
@nl
Torsten Kessler
@sl
prefLabel
Torsten Kessler
@ast
Torsten Kessler
@en
Torsten Kessler
@es
Torsten Kessler
@nl
Torsten Kessler
@sl
P214
P244
P1053
S-3319-2016
P106
P21
P214
P244
nb2010000633
P31
P3829
P496
0000-0001-7679-5362
P734
P735
P7859
lccn-nb2010000633